Skip to main content

Table 1 Effects of feG on the binding of antibodies to cell adhesion and associated molecules in PAF-stimulated cells.

From: Modulation of neutrophil function by the tripeptide feG

Antibody Isotype Control Control PAF PAF & feG1 % Change
CD11a 5.2 ± 0.62 27.7 ± 5.9 30.6 ± 4.5 34.6 ± 5.0 +11 ± 33
CD11b 4.2 ± 0.4 148.1 ± 12.8 291.6 ± 14.1# 242.1 ± 16.3* -17 ± 4 (-34)4
CD11c 5.7 ± 0.2 38.2 ± 6.8 52.4 ± 7.3 47.9 ± 6.0 -9 ± 5
CD14 5.8 ± 0.3 17.9 ± 1.8 33.7 ± 1.2# 32.5 ± 1.8 -4 ± 3
CD16b 19.8 ± 2.9 357.4 ± 55.4 450.7 ± 62.5 297.9 ± 53.2* -33 ± 7 (-164)4
CD18 4.6 ± 0.5 85.7 ± 3.5 95.6 ± 2.9 94.6 ± 2.1 -1 ± 3
CD43 2.9 ± 0.2 48.5 ± 5.7 23.3 ± 3.2 22.4 ± 3.1 -4 ± 2
CD62L 4.5 ± 0.4 57.6 ± 4.8 27.1 ± 2.4 29.2 ± 2.5 +8 ± 5
CD87 8.7 ± 1.9 40.7 ± 6.6 41.0 ± 3.0 44.1 ± 1.6 +7 ± 4
CD162 51.0 ± 13.9 307.4 ± 40.0 222.7 ± 23.9 219.2 ± 46.4 -2 ± 3
  1. 1Concentration of feG = 10-11M. 2 Values expressed as mean ± SEM of Mean Fluorescence Intensity for n = 4–14. 3 Percent change between PAF and PAF & feG. 4 Percent change after subtraction of Control MFI from that of PAF and PAF & feG (Net MFI). Significance (P < 0.05): # greater than Control; * = less than PAF alone; less than Control.